Abstract
Nanomaterials can assist targeted bacterial depletion in either a passive or active way to enhance inhibitory activity and reduce side effects by increasing local concentration of antibacterial agents. In this review article, we summarize the recent development in the field, which will promote more innovative thinking particularly focusing on the treatment of multidrug resistant bacteria.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
